Barclays Lowers Price Target on F&G Annuities & Life Amid Mixed Earnings Results

Barclays recently adjusted its price target for F&G Annuities & Life (NYSE:FG) from $40.00 to $37.00, maintaining an equal weight rating on the stock. F&G opened at $31.19 recently, showing performance below the mid-term moving averages with a 50-day average of $32.41 and a 200-day average of $37.57. The company's market capitalization stands at $4.20 billion with a price-to-earnings ratio of 8.27 and a beta of 1.55, highlighting moderate volatility compared to the market.

The most recent quarterly earnings disclosed by F&G indicate an earnings per share (EPS) of $0.72, falling short of analysts' consensus of $1.19. Nonetheless, revenues exceeded expectations at $2.18 billion versus the anticipated $1.46 billion. The insurer posted a return on equity of 12.89% and a net margin close to 10%, reflecting operational profitability amid earnings miss.

Corporate insider activity includes CEO Christopher O. Blunt's acquisition of 15,000 shares valued at approximately $461,700, increasing his stake by 1.71%. Insiders collectively purchased 45,000 shares over the last quarter, signifying confidence or strategic positioning within the company. Insiders currently hold 2.10% ownership of outstanding shares.

Institutional investors continue to adjust their holdings, with several funds incrementally increasing positions during the latest quarter. Hedge funds and other institutional investors command a significant 95.86% of the company's shares, indicating concentrated ownership and potential influence on corporate strategy.

F&G Annuities & Life primarily focuses on fixed annuity and life insurance products, including retirement and wealth transfer planning. Founded in 1959 and headquartered in Des Moines, Iowa, the company serves a key role in the life insurance and annuity market, providing essential products for long-term financial security and risk management.

Market analysts anticipate an EPS of 5.54 for the current fiscal year, underpinning expectations for improved earnings performance relative to recent quarterly shortfalls. The stock’s recent price fluctuations and adjusted analyst outlook underscore the importance of ongoing monitoring for risks and opportunities amid evolving market conditions in the insurance sector.